EXAS

Exact Sciences Corp (EXAS) Investor Questions

Review Exact Sciences Corp (EXAS) faq with company data, supporting context and links to related investor research.

Research record updated: . Individual measures may refer to different reporting periods.

Company
Exact Sciences Corp
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Overall BTI score
63
Annual revenue
$3.25B
Annual net income
$-207.95M
Annual free cash flow
$356.78M

Exact Sciences Corp (EXAS) Investor Questions research

Exact Sciences Corp trades under the ticker EXAS. The company is classified in the Healthcare sector and the Medical - Diagnostics & Research industry.

Investors commonly review EXAS through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.